Skip to main content

Imfinzi Prices, Coupons and Patient Assistance Programs

Imfinzi (durvalumab) is a member of the anti-PD-1 monoclonal antibodies drug class and is commonly used for Non-Small Cell Lung Cancer, and Small Cell Lung Cancer.

Imfinzi prices

The cost for Imfinzi intravenous solution (50 mg/mL) is around $978 for a supply of 2.4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Imfinzi price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intravenous Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Imfinzi Coupons and Rebates

Imfinzi offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Imfinzi Access 360 Co-pay Savings Program: Eligible commercially insured patients may pay $0 per infusion out-of-pocket costs with a savings of up to $26,000 per year; out-of-pocket costs covered include the cost of the product itself and/or the cost of infusion of the product (program maximum of $100 per infusion); for additional information contact the program at 844-275-2360.

Applies to:
Imfinzi
Number of uses:
per prescription per year

Form more information phone: 844-275-2360 or Visit website

Patient Assistance Programs for Imfinzi

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: AZ&Me Prescription Savings Program for people without insurance

Elligibility requirements:
  1. Must have no prescription coverage for needed medication
  2. Varies
  3. Not required
  4. The patient must also be a US resident.
  5. People who are in Medicare and may be eligible for the Limited Income Subsidy can apply. However, if they are accepted into the LIS, they are no longer eligible for the AZ& Me Prescription Savings Program. Eligibility determined on a case-by-case basis.
Applicable drugs:
  • Imfinzi (durvalumab) Injection; IV

More information please phone: 800-292-6363 Visit Website

Provider: AZ&Me Prescription Savings Program for people with Medicare Part D

Elligibility requirements:
  1. Contact program for details.
  2. Varies
  3. Not required
  4. The patient must also be a US resident.
  5. Eligibility determined on a case-by-case basis. *Patient must participate in Medicare Part B, Medicare Part D or Medicare Advantage
Applicable drugs:
  • Imfinzi (durvalumab) Injection; IV

More information please phone: 800-292-6363 Visit Website

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Imfinzi (durvalumab) Injection; IV

More information please phone: 866-316-7263 Visit Website